{
    "Trade/Device Name(s)": [
        "VITEK 2 Streptococcus Tetracycline (\u2264 0.25 - \u2265 16 \u00b5g/mL)"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K223481",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111893"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "November 17, 2022",
    "Summary Letter Received Date": "November 18, 2022",
    "Submission Date": "February 02, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tetracycline"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Streptococcus species"
    ],
    "Specimen Container(s)": [
        "Saline suspension"
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility testing",
        "Microdilution minimum inhibitory concentration (MIC)"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Microdilution"
    ],
    "Submission Type(s)": [
        "Test",
        "Susceptibility Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Streptococcus Tetracycline AST card for automated MIC-based susceptibility testing on VITEK 2 platforms",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Streptococcus species, including Streptococcus pneumoniae, Streptococcus pyogenes, and beta-hemolytic Streptococcus, to determine in vitro susceptibility to tetracycline using VITEK 2 systems.",
    "fda_folder": "Microbiology"
}